The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Functional and oncological outcome of primary nerve sparing retroperitoneal lymph node dissection in marker negative testicular germ cell tumors in clinical stage IIA/B.
 
Julian Heidenreich
Honoraria - Amgen (I); Astellas Pharma (I); Bayer (I); Ferring (I); Ipsen (I); Janssen-Cilag (I); Sanofi (I); Takeda (I)
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (I); Bayer (I); Bristol-Myers Squibb (I); Clovis Oncology (I); Janssen-Cilag (I); MSD Oncology (I)
Speakers' Bureau - Amgen (I); Astellas Pharma (I); Bayer (I); Ipsen (I); Johnson & Johnson (I); Pfizer (I); Sanofi (I); Takeda (I)
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - BMS Oncology